Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms.
M Walter, … , U Seedorf, G Assmann
M Walter, … , U Seedorf, G Assmann
Published November 15, 1996
Citation Information: J Clin Invest. 1996;98(10):2315-2323. https://doi.org/10.1172/JCI119043.
View: Text | PDF
Research Article

Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms.

  • Text
  • PDF
Abstract

The negative correlation between coronary heart disease and plasma levels of HDL has been attributed to the ability of HDL to take up cellular cholesterol. The HDL3-induced removal of cellular cholesterol was reported to be impaired in fibroblasts from patients with familial HDL deficiency (Tangier disease, TD). In addition, we have recently shown that HDL3 stimulates the hydrolysis of phosphatidylcholine (PC) in cholesterol-loaded fibroblasts. To investigate whether this cell signaling pathway is involved in cholesterol efflux mechanisms, we compared the HDL3-induced PC hydrolysis in normal fibroblasts and in fibroblasts from a TD kindred, in whom the HDL3- and apolipoprotein A-I (apo A-I)-induced mobilization of cellular cholesterol was found to be reduced by 50%. The HDL3-induced formation of phosphatidic acid (PA) via PC-specific phospholipase D (PC-PLD) was markedly reduced by 60-80% in these cells, whereas the formation of diacylglycerol (DG) via PC-specific phospholipase C (PC-PLC) was two- to threefold enhanced. Defective regulation of PC-PLC and PC-PLD was similarly observed in response to apo A-I and endothelin, but not in response to the receptor-independent stimulation of PC hydrolysis by PMA. A Tangier-like PA and DG formation pattern could be induced in normal cells after preincubation with pertussis toxin, suggesting the involvement of a G-protein. The impaired mobilization of radiolabeled cellular cholesterol in TD cells could completely be overcome by increasing the PA levels in the presence of the PA phosphohydrolase inhibitor propranolol. Conversely, the inhibition of PA formation in the presence of 0.3% butanol as well as the inhibition of DG formation in the presence of the PC-PLC inhibitor D 609 reduced the mobilization of cellular cholesterol both in normal and in TD cells. Our data indicate that the coordinate formation of PA and DG via PC-PLD and PC-PLC is essential for efficient cholesterol efflux. The molecular defect in this TD kindred appears to affect an upstream effector of protein kinase C responsible for the G-protein-dependent regulation of PC-specific phospholipases.

Authors

M Walter, H Reinecke, U Gerdes, J R Nofer, G Höbbel, U Seedorf, G Assmann

×

Total citations by year

Year: 2018 2015 2014 2013 2009 2008 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 Total
Citations: 1 1 8 1 1 1 2 3 2 4 1 8 8 2 4 1 48
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (48)

Title and authors Publication Year
Adenylyl cyclase 1 as a major isoform to generate cAMP signaling for apoA-1-mediated cholesterol efflux pathway
W Tang, W Ma, H Ding, M Lin, L Xiang, G Lin, Z Zhang
Journal of lipid research 2018
Mesenchymal Stem Cells Respond to Hypoxia by Increasing Diacylglycerols: H YPOXIA I NCREASES DG L EVELS IN MSC
K Lakatos, S Kalomoiris, B Merkely, JA Nolta, FA Fierro
Journal of Cellular Biochemistry 2015
High Density Lipoproteins: From Biological Understanding to Clinical Exploitation
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins: From Biological Understanding to Clinical Exploitation
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins: From Biological Understanding to Clinical Exploitation
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins: From Biological Understanding to Clinical Exploitation
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins: From Biological Understanding to Clinical Exploitation
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins: From Biological Understanding to Clinical Exploitation
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins: From Biological Understanding to Clinical Exploitation
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins: From Biological Understanding to Clinical Exploitation
A von Eckardstein, D Kardassis
2014
Characterization of Cholesterol Homeostasis in Telomerase-immortalized Tangier Disease Fibroblasts Reveals Marked Phenotype Variability
F Kannenberg, K Gorzelniak, K Jager, M Fobker, S Rust, J Repa, M Roth, I Bjorkhem, M Walter
2013
Hepatic uptake and metabolism of phosphatidylcholine associated with high density lipoproteins
JC Robichaud, JN van der Veen, Z Yao, B Trigatti, DE Vance
Biochimica et Biophysica Acta (BBA) - General Subjects 2009
Conversion of Low Density Lipoprotein-associated Phosphatidylcholine to Triacylglycerol by Primary Hepatocytes
C Minahk, KW Kim, R Nelson, B Trigatti, R Lehner, DE Vance
The Journal of biological chemistry 2008
Protease-activated receptors differentially regulate human platelet activation through a phosphatidic acid-dependent pathway
M Holinstat, B Voss, ML Bilodeau, HE Hamm
Molecular pharmacology 2006
New insights into the biogenesis of human high-density lipoproteins
L Krimbou, M Marcil, J Genest
Current Opinion in Lipidology 2006
Signalling and regulation of collagen I synthesis by ET-1 and TGF-beta1
A Horstmeyer, C Licht, G Scherr, B Eckes, T Krieg
FEBS Journal 2005
Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux
RS Kiss, J Maric, YL Marcel
Journal of lipid research 2005
ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease
JF Oram, JW Heinecke
Physiological reviews 2005
Triglyceride-rich lipoproteins inhibit cholesterol efflux to apolipoprotein (apo) A1 from human macrophage foam cells
AM Palmer, N Murphy, A Graham
Atherosclerosis 2004
The ins and outs of reverse cholesterol transport
A Groen, RO Elferink, H Verkade, F Kuipers
Annals of Medicine 2004
Ceramide Enhances Cholesterol Efflux to Apolipoprotein A-I by Increasing the Cell Surface Presence of ATP-binding Cassette Transporter A1
SR Witting, JN Maiorano, WS Davidson
The Journal of biological chemistry 2003
Apolipoprotein A-I Activates Protein Kinase Cα Signaling to Phosphorylate and Stabilize ATP Binding Cassette Transporter A1 for the High Density Lipoprotein Assembly
Y Yamauchi, M Hayashi, S Abe-Dohmae, S Yokoyama
The Journal of biological chemistry 2003
Apolipoprotein A-I Activates Cellular cAMP Signaling through the ABCA1 Transporter
B Haidar, M Denis, M Marcil, L Krimbou, J Genest
The Journal of biological chemistry 2003
Cholesterol Distribution in the Golgi Complex of DITNC1 Astrocytes Is Differentially Altered by Fresh and Aged Amyloid β-Peptide-(1–42)
U Igbavboa, JM Pidcock, LN Johnson, TM Malo, AE Studniski, S Yu, GY Sun, WG Wood
The Journal of biological chemistry 2003
HDL and arteriosclerosis: beyond reverse cholesterol transport
JR Nofer, B Kehrel, M Fobker, B Levkau, G Assmann, A Eckardstein
Atherosclerosis 2002
Accumulation of RhoA, RhoB, RhoG, and Rac1 in Fibroblasts from Tangier Disease Subjects Suggests a Regulatory Role of Rho Family Proteins in Cholesterol Efflux
M Utech, G Höbbel, S Rust, H Reinecke, G Assmann, M Walter
Biochemical and Biophysical Research Communications 2001
Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis
A Brooks-Wilson, M Marcil, SM Clee, LH Zhang, K Roomp, M Dam, L Yu, C Brewer, JA Collins, HO Molhuizen, O Loubser, BF Ouelette, K Fichter, KJ Ashbourne-Excoffon, CW Sensen, S Scherer, S Mott, M Denis, D Martindale, J Frohlich, K Morgan, B Koop, S Pimstone, JJ Kastelein, J Genest, MR Hayden
Journal of lipid research 2001
Accumulation of cardiolipin and lysocardiolipin in fibroblasts from Tangier disease subjects
M Fobker, R Voss, H Reinecke, C Crone, G Assmann, M Walter
FEBS Letters 2001
Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis
A Brooks-Wilson, M Marcil, SM Clee, LH Zhang, K Roomp, M Dam, L Yu, C Brewer, JA Collins, HO Molhuizen, O Loubser, BF Ouelette, K Fichter, KJ Ashbourne-Excoffon, CW Sensen, S Scherer, S Mott, M Denis, D Martindale, J Frohlich, K Morgan, B Koop, S Pimstone, JJ Kastelein, J Genest, MR Hayden
Journal of lipid research 2001
Endocytosis Is Enhanced in Tangier Fibroblasts: POSSIBLE ROLE OF ATP-BINDING CASSETTE PROTEIN A1 IN ENDOSOMAL VESICULAR TRANSPORT
X Zha, J Genest, R McPherson
The Journal of biological chemistry 2001
High Density Lipoproteins and Arteriosclerosis: Role of Cholesterol Efflux and Reverse Cholesterol Transport
A von Eckardstein, JR Nofer, G Assmann
Arteriosclerosis, thrombosis, and vascular biology 2001
Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts
B Haidar, S Mott, B Boucher, CY Lee, M Marcil, J Genest
Journal of lipid research 2001
Intracellular cholesterol and phospholipid trafficking: comparable mechanisms in macrophages and neuronal cells
G Schmitz, E Orsó
Neurochemical Research 2001
ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins
JF Oram, AM Vaughan
Current Opinion in Lipidology 2000
Tangier disease and ABCA1
J Oram
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2000
Phospholipase D: molecular and cell biology of a novel gene family
M Liscovitch, M Czarny, G Fiucci, X Tang
Biochemical Journal 2000
Cholesterol efflux from normal and Tangier disease fibroblasts into normal, high-density lipoprotein-deficient, and apolipoprotein E-deficient plasmas
S Schuler-Lüttmann, Y Zhu, M Hoffmann, W März, G Feussner, H Wieland, G Assmann, A Eckardstein
Metabolism 2000
Involvement of phospholipase D in store-operated calcium influx in vascular smooth muscle cells
M Walter, M Tepel, JR Nofer, M Neusser, G Assmann, W Zidek
FEBS Letters 2000
Novel mutations in the gene encoding ATP-binding cassette 1 in four tangier disease kindreds
ME Brousseau, EJ Schaefer, J Dupuis, B Eustace, PV Eerdewegh, AL Goldkamp, LM Thurston, MG FitzGerald, D Yasek-McKenna, G O'Neill, GP Eberhart, B Weiffenbach, JM Ordovas, MW Freeman, RH Brown, JZ Gu
Journal of lipid research 2000
Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations
S Mott, L Yu, M Marcil, B Boucher, C Rondeau, J Genest Jr
Atherosclerosis 2000
Activation of Phosphatidylinositol-Specific Phospholipase C by HDL-Associated Lysosphingolipid. Involvement in Mitogenesis but Not in Cholesterol Efflux
JR Nofer, M Fobker, G Höbbel, R Voss, I Wolinska, M Tepel, W Zidek, R Junker, U Seedorf, A von Eckardstein, G Assmann, M Walter
Biochemistry 2000
Effluxed lipids: Tangier Island's latest export
MW Freeman
Proceedings of the National Academy of Sciences 1999
Growth and Cell Cycle Abnormalities of Fibroblasts From Tangier Disease Patients
W Drobnik, G Liebisch, C Biederer, B Trümbach, G Rogler, P Müller, G Schmitz
Arteriosclerosis, thrombosis, and vascular biology 1999
Apolipoprotein-mediated cellular cholesterol efflux
S Yokoyama
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1998
Stimulation of DNA Synthesis in Untransformed Cells by the Antiviral and Antitumoral Compound Tricyclodecan-9-yl-xanthogenate (D609)
Z Kiss, KS Crilly, T Chung
Biochemical Pharmacology 1998
Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy
S Rust, M Walter, H Funke, A Eckardstein, P Cullen, HY Kroes, R Hordijk, J Geisel, J Kastelein, HO Molhuizen, M Schreiner, A Mischke, HW Hahmann, G Assmann
Nature Genetics 1998
Plasma and fibroblasts of Tangier disease patients are disturbed in transferring phospholipids onto apolipoprotein A-I
A von Eckardstein, A Chirazi, S Schuler-Lüttmann, M Walter, JJ Kastelein, J Geisel, JT Real, R Miccoli, G Noseda, G Höbbel, G Assmann
Journal of lipid research 1998
Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion
AJ Mendez
Journal of lipid research 1997

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts